QQ客服 官方微博 反馈留言

	A new concept of enhancing immuno-chemotherapeutic effects against B16F10 tumor via systemic administration by taking advantages of the limitation of EPR effect
	Yang, Y.; Tai, X.; Shi, K.; Ruan, S.; Qiu, Y.; Zhang, Z.; Xiang, B.; He, Q.
刊名	Theranostics
	2016
卷号	Vol.6 No.12页码:2141-2160
关键词	Alpha-galactosylceramide Cancer immune-chemotherapy Distribution characteristic Liposome Paclitaxel
ISSN号	1838-7640
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1819999
专题	四川大学
作者单位	1.Southern Renmin Road, Chengdu, China 2.Department of hematology, West China Hospital, Sichuan university, No., 17, Block 3, Southern Renmin Road, Chengdu, China 3.a Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Block, 3,
推荐引用方式 GB/T 7714	Yang, Y.,Tai, X.,Shi, K.,et al. A new concept of enhancing immuno-chemotherapeutic effects against B16F10 tumor via systemic administration by taking advantages of the limitation of EPR effect[J]. Theranostics,2016,Vol.6 No.12:2141-2160.
APA	Yang, Y..,Tai, X..,Shi, K..,Ruan, S..,Qiu, Y..,...&He, Q..(2016).A new concept of enhancing immuno-chemotherapeutic effects against B16F10 tumor via systemic administration by taking advantages of the limitation of EPR effect.Theranostics,Vol.6 No.12,2141-2160.
MLA	Yang, Y.,et al."A new concept of enhancing immuno-chemotherapeutic effects against B16F10 tumor via systemic administration by taking advantages of the limitation of EPR effect".Theranostics Vol.6 No.12(2016):2141-2160.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。